PDCD1LG2 and neoplasm: The first two members of the B7 family, PD-L1 and PD-L2, are well known immune checkpoint molecules which inhibit T cell proliferation upon interaction with the PD-1 receptor on the surface of T cells, thus allowing immune escape of the tumor cells (Boussiotis, 2016).